Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group (DARENCA) study-2-Reference-Cited by-同舟云学术

Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group (DARENCA) study-2

Published:2014-02 Issue:3 Volume:50 Page:553-562
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Soerensen Anne V.,Donskov Frede,Hermann Gregers G.,Jensen Niels V.,Petersen Astrid,Spliid Henrik,Sandin Rickard,Fode Kirsten,Geertsen Poul F.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007

2. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

3. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma;Hudes;N Engl J Med,2007

4. Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors;Motzer;Cancer,2010

5. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial;Sternberg;J Clin Oncol,2010

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Drug Monitoring for Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma;Clinical Genitourinary Cancer;2024-06

2. The Impact of COVID-19 on New Kidney Cancer Diagnosis: Stage and Treatment in Northern Italy;International Journal of Environmental Research and Public Health;2023-03-08

3. Survival and Functional Outcomes after Surgical Treatment for Spinal Metastasis in Patients with a Short Life Expectancy;Journal of Clinical Medicine;2022-12-21

4. Individualizing the Oncological Treatment of Patients With Metastatic Non–Clear Cell Renal Cell Carcinoma by Using Gene Sequencing and Patient-Reported Outcomes: Protocol for the INDIGO Study;JMIR Research Protocols;2022-09-15

5. The role of hepatic and pancreatic metastatectomy in the management of metastatic renal cell carcinoma: A systematic review;Surgical Oncology;2022-09